Absci Announces Participation in Piper Sandler's 35th Annual Healthcare Conference

VANCOUVER, Wash. and NEW YORK – November 15, 2023 – Absci Corporation ABSI, a pioneer in generative artificial intelligence (AI) for drug creation, is confirmed to take part in the distinguished Piper Sandler 35th Annual Healthcare Conference. This event, a cornerstone within the healthcare investment community, provides a platform for growing and established companies in the sector to connect with influential industry stakeholders and investors. The conference is slated to take place in New York, NY, consolidating its status as a key venue for business development and market insights.

Absci's Innovative Footprint in Drug Creation

Commanding attention in the biopharmaceutical sphere, ABSI leverages cutting-edge AI to revolutionize the drug development process. This distinct approach positions ABSI at the forefront of innovation, potentially disrupting traditional methods and significantly reducing timeframes for bringing new therapeutics to the market. As drug creation continues to advance rapidly, this conference appearance will likely provide ABSI an opportunity to showcase its expertise and possibly attract further investment and collaboration interests.

Alphabet's Shadow Over Healthcare Investments

While not directly affiliated with healthcare, Alphabet Inc. GOOG, the parent company of internet giant Google, casts a long influence across numerous sectors, including healthcare. GOOG's stature as one of the globe's paramount tech conglomerates often places it indirectly in investment conversations around industries it touches with its expansive technology and resources. This occasion will also highlight the interest of conglomerates like Alphabet in the burgeoning field of AI in healthcare, marking the intersection of technology and medicine as an epicenter for noteworthy investments.

Absci, AI, Healthcare, Investment, Conference